Company profile EVLO

Evelo Biosciences Inc
evelo biosciences is dedicated to improving the lives of patients globally through the development of a new modality of medicines – monoclonal microbials. monoclonal microbials are orally delivered medicines that modulate systemic immunology and biology through direct interactions with human cells in the gut. these new medicines are broadly applicable across many diseases –... including autoimmune, immunoinflammatory, metabolic, neurological, neuroinflammatory diseases and cancer. monoclonal microbials have the potential to fundamentally change traditional models of drug discovery and development. by finding and selecting naturally occurring monoclonal microbials with defined therapeutic effects, evelo can improve the speed, cost and success of drug discovery and development. evelo’s platform enables pharmacological intervention at all stages of disease with naturally occurring, safe and effective monoclonal microbials. evelo biosciences was conceived and created within venturelabs®, flag Show More
Quarter analysis & expected interest

There is not enough data for Evelo Biosciences company to provide analysis

Correlation between past revenue and Evelo Biosciences company search interest

There is not enough data for Evelo Biosciences company to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Evelo Biosciences company to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 00:37:15.

After 38 days of this quarter the interest is at 54.0. Based on that we can calculate that during remaining 53 days it will total up to 129.0.
Evelo Biosciences stock expected interest is significantly higher compared to previous quarter (+101.6%) but similar to same quarter last year.

YearQ1Q2Q3Q4
201964
76
18.8% QoQ
133
75.0% QoQ
99
-25.6% QoQ
2020 44
-31.2% YoY -55.6% QoQ
187
146.1% YoY 325.0% QoQ
88
-33.8% YoY -52.9% QoQ
78
-21.2% YoY -11.4% QoQ
2021 108
145.5% YoY 38.5% QoQ
98
-47.6% YoY -9.3% QoQ
89
1.1% YoY -9.2% QoQ
56
-28.2% YoY -37.1% QoQ
2022 57
-47.2% YoY 1.8% QoQ
107
9.2% YoY 87.7% QoQ
39
-56.2% YoY -63.6% QoQ
46
-17.9% YoY 17.9% QoQ
2023 168
194.7% YoY 265.2% QoQ
104
-2.8% YoY -38.1% QoQ
140
259.0% YoY 34.6% QoQ
64
39.1% YoY -54.3% QoQ
2024 54
-67.9% YoY -15.6% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Evelo Biosciences stock search interestLast update: February 08 2024 00:37:15.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 00:37:16.

The average 5 years interest of Evelo Biosciences stock was 7.3 per week.
The last year interest of Evelo Biosciences stock compared to the last 5 years has changed by 23.56%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 21.24%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for EDP1815 clinical trial to provide analysis

Correlation between past revenue and EDP1815 clinical trial search interest

There is not enough data for EDP1815 clinical trial to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for EDP1815 clinical trial to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for EDP1867 Phase 1b trial to provide analysis

Correlation between past revenue and EDP1867 Phase 1b trial search interest

There is not enough data for EDP1867 Phase 1b trial to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for EDP1867 Phase 1b trial to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for EDP2939 investigational oral biologic to provide analysis

Correlation between past revenue and EDP2939 investigational oral biologic search interest

There is not enough data for EDP2939 investigational oral biologic to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for EDP2939 investigational oral biologic to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for EDP1908 oncology to provide analysis

Correlation between past revenue and EDP1908 oncology search interest

There is not enough data for EDP1908 oncology to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for EDP1908 oncology to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Evelo Biosciences headquarters to provide analysis

Correlation between past revenue and Evelo Biosciences headquarters search interest

There is not enough data for Evelo Biosciences headquarters to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Evelo Biosciences headquarters to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Evelo Biosciences contact to provide analysis

Correlation between past revenue and Evelo Biosciences contact search interest

There is not enough data for Evelo Biosciences contact to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Evelo Biosciences contact to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Evelo Biosciences sector to provide analysis

Correlation between past revenue and Evelo Biosciences sector search interest

There is not enough data for Evelo Biosciences sector to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Evelo Biosciences sector to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for EVLO
Earnings date: 2024-03-14 After close
Company name: Evelo Biosciences Inc
Sector: Professional, Scientific, and Technical Services
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2024-07-17T08:00:00-04:00

PR Newswire
Alltrna Announces Updates to Its Board of Directors

2024-03-11T00:15:15-04:00

SEC
EFFECT Form - Notice of Effectiveness - Evelo Biosciences, Inc. (0001694665) (Filer)

2024-01-26T17:30:25-05:00

SEC
15-12G Form - Securities registration termination [Section 12(g)] - Evelo Biosciences, Inc. (0001694665) (Filer)

2024-01-26T17:29:48-05:00

SEC
S-8 POS Form - Securities to be offered to employees in employee benefit plans, post-effective amendments - Evelo Biosciences, Inc. (0001694665) (Filer)

2024-01-26T17:28:32-05:00

SEC
S-8 POS Form - Securities to be offered to employees in employee benefit plans, post-effective amendments - Evelo Biosciences, Inc. (0001694665) (Filer)

2024-01-26T17:27:26-05:00

SEC
POS AM Form - Post-Effective amendments for registration statement - Evelo Biosciences, Inc. (0001694665) (Filer)

2024-01-26T17:26:57-05:00

SEC
8-K Form - Current report, item 5.07 - Evelo Biosciences, Inc. (0001694665) (Filer)

2023-12-27T09:02:24-05:00

SEC
25-NSE Form - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities - Evelo Biosciences, Inc. (0001694665) (Subject)

2023-12-12T07:43:35-05:00

SEC
DEFA14A Form - Additional definitive proxy soliciting materials and Rule 14(a)(12) material - Evelo Biosciences, Inc. (0001694665) (Filer)

2023-12-12T07:42:04-05:00

SEC
DEF 14A Form - Other definitive proxy statements - Evelo Biosciences, Inc. (0001694665) (Filer)

2023-12-11T09:09:54-05:00

SEC
SC 13G/A Form - [Amend] Statement of acquisition of beneficial ownership by individuals - Evelo Biosciences, Inc. (0001694665) (Subject)

2023-12-04T06:04:28-05:00

SEC
8-K Form - Current report, item 3.01 - Evelo Biosciences, Inc. (0001694665) (Filer)

2023-12-01T07:11:59-05:00

SEC
PRE 14A Form - Other preliminary proxy statements - Evelo Biosciences, Inc. (0001694665) (Filer)

2023-11-21T06:44:05-05:00

SEC
8-K Form - Current report, items 5.02, 8.01, and 9.01 - Evelo Biosciences, Inc. (0001694665) (Filer)

2023-11-13T09:02:39-05:00

SEC
SC 13G/A Form - [Amend] Statement of acquisition of beneficial ownership by individuals - Evelo Biosciences, Inc. (0001694665) (Subject)